Lunasin (lunasin) vs Qalsody (tofersen)

Lunasin is a peptide that has been studied for its potential health benefits, including anti-inflammatory and anticancer properties, although it is not approved by the FDA for the treatment of any specific medical condition. On the other hand, Qalsody (tofersen) is an antisense oligonucleotide drug specifically designed for the treatment of amyotrophic lateral sclerosis (ALS) in patients with a confirmed SOD1 genetic mutation, and it has been granted FDA approval for this indication. When deciding between Lunasin and Qalsody, it is crucial to consider the specific medical condition being treated, as Qalsody is targeted for a particular form of ALS, while Lunasin does not have an approved therapeutic indication and its efficacy and safety for specific conditions have not been established in large-scale clinical trials.

Difference between Lunasin and Qalsody

Metric	Lunasin (lunasin)	Qalsody (tofersen)
Generic name	Lunasin	Tofersen
Indications	Not specified for medical use; studied for potential health benefits	Treatment of Amyotrophic lateral sclerosis (ALS) with SOD1 mutation
Mechanism of action	May influence epigenetic factors and have anti-inflammatory, antioxidant properties	Antisense oligonucleotide that reduces SOD1 protein production
Brand names	Not applicable	Qalsody
Administrative route	Oral (as a dietary supplement)	Intrathecal injection
Side effects	Not well documented	Headache, back pain, fall, and pain in extremity
Contraindications	Not well established	None known specifically; use caution in patients with renal impairment or thrombocytopenia
Drug class	Not classified as a drug	Antisense oligonucleotide
Manufacturer	Various dietary supplement manufacturers	Biogen

Efficacy

Lunasin and Amyotrophic Lateral Sclerosis (ALS)

Lunasin is a peptide that has been studied for its potential health benefits, including its role in the treatment of Amyotrophic Lateral Sclerosis (ALS). ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. While research on lunasin is still in the early stages, some preclinical studies have suggested that it may have neuroprotective effects that could be beneficial for patients with ALS. However, clinical data on the efficacy of lunasin for ALS is limited, and more research is needed to establish its potential therapeutic role in this condition.

Qalsody (Tofersen) and Amyotrophic Lateral Sclerosis (ALS)

Qalsody (tofersen) is an investigational drug specifically designed for the treatment of ALS caused by mutations in the superoxide dismutase 1 (SOD1) gene, which is one of the genetic causes of the disease. Tofersen is an antisense oligonucleotide that targets the SOD1 mRNA, aiming to reduce the production of the abnormal SOD1 protein that is toxic to motor neurons. The efficacy of Qalsody in slowing the progression of ALS has been evaluated in clinical trials.

In a Phase 1/2 clinical trial, tofersen demonstrated a reduction in SOD1 protein levels in the cerebrospinal fluid of patients with SOD1-ALS. Following these results, the Phase 3 clinical trial, known as VALOR, was conducted to further assess the efficacy and safety of tofersen. The trial aimed to evaluate whether tofersen could slow down the decline in motor function and improve survival rates in patients with SOD1-ALS.

While the results from the VALOR trial have shown promise, the full extent of Qalsody's efficacy in treating ALS remains under investigation. The U.S. Food and Drug Administration (FDA) has not yet approved tofersen for the treatment of ALS, and its use is currently limited to clinical trials. Patients with ALS who are interested in participating in clinical trials for tofersen or other investigational drugs should consult with their healthcare providers for more information and eligibility criteria.

Regulatory Agency Approvals

Lunasin

Food and Drug Administration (FDA), USA

Qalsody

European Medical Agency (EMA), European Union
Food and Drug Administration (FDA), USA

Access Lunasin or Qalsody today

If Lunasin or Qalsody are not approved or available in your country (e.g. due to supply issues), you can access them via Everyone.org.

Buy Lunasin

Buy Qalsody

How it works

Make an enquiry

Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.

Breeze through the paperwork

We'll guide you through the required documents for importing unapproved medicine, ensuring you have all the necessary information.

Get a personalized quote

We’ll prepare a quote for you, including medicine costs and any shipping, administrative, or import fees that may apply.

Receive your medicine

Accept the quote and we’ll handle the rest - sourcing and safely delivering your medicine.

Some text on this page has been automatically generated. Speak to your physician before you start a new treatment or medication.

Let's talk

If you have any questions, call us or send us a message through WhatsApp or email: